Next therapy for Covid maybe be at your local pharmacy

20-08-2021 Fri 11:47 IST | IANS | Health

New York, Aug 20 : Several drugs that are already in use for other purposes, including one dietary supplement, have shown to block or reduce infection by SARS-CoV2, the virus causing Covid-19, in cells, researchers have found.

The study, published in the Proceedings of the National Academy of Science, uses artificial intelligence-powered image analysis of human cell lines during infection with the novel coronavirus.

The cells were treated with more than 1,400 individual US Food and Drug Administration-approved drugs and compounds, either before or after viral infection, and screened, resulting in 17 potential hits.

Ten of those hits were newly recognised, with seven identified in previous drug repurposing studies, including remdesivir, which is one of the few FDA-approved therapies for Covid-19 in hospitalised patients.

"Traditionally, the drug development process takes a decade -- and we just don't have a decade," said Jonathan Sexton, Assistant Professor of Internal Medicine at the University of Michigan Medical School.

"The therapies we discovered are well positioned for phase 2 clinical trials because their safety has already been established," he added.

The team validated the 17 candidate compounds in several types of cells, including stem-cell derived human lung cells in an effort to mimic SARS-CoV2 infection of the respiratory tract.

Nine showed antiviral activity at reasonable doses, including lactoferrin, a protein found in human breast milk that is also available over the counter as a dietary supplement derived from cow's milk.

"We found lactoferrin had remarkable efficacy for preventing infection, working better than anything else we observed," Sexton said.

He added that early data suggest this efficacy extends even to newer variants of SARS-CoV2, including the highly transmissible Delta variant.

The team aims to soon launch clinical trials of the compound to examine its ability to reduce viral loads and inflammation in patients with SARS-CoV2 infection.

The study also identified a class of compounds called MEK-inhibitors, typically prescribed to treat cancer, that appear to worsen SARS-CoV2 infection.

The finding sheds light on how the virus spreads among cells.

"People going in for chemotherapy are at risk already due to a lowered immune response. We need to investigate whether some of these drugs worsen disease progression," said Sexton.


More News
Russian film crew wraps shooting in space, returns to Earth
1 hour ago
New wearable device uses sweat to monitor glucose levels
1 hour ago
MAA president Manchu Vishnu's overenthusiastic tweet goes viral
1 hour ago
Sasikala inaugurates AIADMK golden jubilee celebrations, calls for unity
2 hours ago
Bill, Melinda Gates walk daughter down the aisle
2 hours ago
Jaishankar arrives in Israel for 3-day visit
2 hours ago
John Cena gets into action in just his underwear in 'Peacemaker' trailer
2 hours ago
BCCI invites applications for Team India head coach's job
2 hours ago
'Bheemla Nayak' composer Thaman felicitates folk singer Mogulaiah
2 hours ago
Slip disc, sciatica can be treated with minimal invasive technique
2 hours ago
Telugu hit 'Love Story' to premiere on AHA OTT soon
3 hours ago
Qadir Ali Baig Theatre Festival in Hyderabad from October 21
3 hours ago
Win the T20 World Cup for Virat Kohli: Suresh Raina
4 hours ago
What made Delta, Delta Plus variants of Covid more virulent
4 hours ago
Decorate your home on a budget in time for the holidays
4 hours ago
Markets in euphoria, corrections are imminent
5 hours ago
Sitharaman's marathon meeting sessions with US businesses continues in NY
5 hours ago
If ISI chief is replaced Imran's govt will fall like a house of cards: Maryam Nawaz
5 hours ago
'Sarkaru Vaari Paata' poster reveals Keerthy Suresh in a sleek avatar
5 hours ago
US lawmakers protest more intensely than Indians over Amazon's rigging in India: CAIT
5 hours ago
I-T searches on groups engaged in business of Digital Marketing & Waste Management
5 hours ago
Terror vs Terror: ISIS-K using Taliban's own killing tools to step up the heat
6 hours ago
All you need to know about India's power crisis
6 hours ago
Sai Dharam Tej's recovery and his wedding news go hand-in-hand
6 hours ago
Does Chiranjeevi dislike appearing on OTT platforms?
7 hours ago
B-Town: Female stars venture into funding
8 hours ago
Spy's Eye: The pillars of nationhood
9 hours ago
'Dashrath' dies on stage, audience claps for 'great' act
9 hours ago
Protest announced against attacks on Hindu temples in Bangladesh
9 hours ago
Superstar Vijay's possible entry into TN politics keenly watched
9 hours ago